Pedro Torres‐González

735 total citations
29 papers, 450 citations indexed

About

Pedro Torres‐González is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Pedro Torres‐González has authored 29 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 17 papers in Epidemiology and 14 papers in Surgery. Recurrent topics in Pedro Torres‐González's work include Tuberculosis Research and Epidemiology (11 papers), Mycobacterium research and diagnosis (9 papers) and Diagnosis and treatment of tuberculosis (6 papers). Pedro Torres‐González is often cited by papers focused on Tuberculosis Research and Epidemiology (11 papers), Mycobacterium research and diagnosis (9 papers) and Diagnosis and treatment of tuberculosis (6 papers). Pedro Torres‐González collaborates with scholars based in Mexico, United States and South Africa. Pedro Torres‐González's co-authors include José Sifuentes‐Osornio, Alfredo Ponce‐de‐León, Miriam Bobadilla-del-Valle, Areli Martínez‐Gamboa, Lourdes García‐García, Luis Pablo Cruz‐Hervert, Miguel E. Cervera-Hernandez, Arturo Galindo‐Fraga, Isabel Sada‐Ovalle and Adrian J. Gonzalez‐Aguirre and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Frontiers in Microbiology.

In The Last Decade

Pedro Torres‐González

26 papers receiving 441 citations

Peers

Pedro Torres‐González
Comparison fields: 5 of 69
  • Infectious Diseases 247
  • Epidemiology 219
  • Molecular Medicine 124
  • Surgery 102
  • Applied Microbiology and Biotechnology 55
Banu Bayraktar Türkiye
Kenan Hızel Türkiye
Li‐Hwei Sng Singapore
Hussam Tabaja United States
Ferhat Arslan Türkiye
Constantin Hays France
Haluk Güri̇z Türkiye
Arghya Das India
Bilge Gültepe Türkiye
Kwok‐Woon Yu Taiwan
Banu Bayraktar Türkiye View profile →
Citations per field, relative to Pedro Torres‐González
Pedro Torres‐González · 1×
Citations per year, relative to Pedro Torres‐González
Pedro Torres‐González · 1×

Countries citing papers authored by Pedro Torres‐González

Since Specialization
Citations

This map shows the geographic impact of Pedro Torres‐González's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pedro Torres‐González with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pedro Torres‐González more than expected).

Fields of papers citing papers by Pedro Torres‐González

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pedro Torres‐González. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pedro Torres‐González. The network helps show where Pedro Torres‐González may publish in the future.

Co-authorship network of co-authors of Pedro Torres‐González

This figure shows the co-authorship network connecting the top 25 collaborators of Pedro Torres‐González. A scholar is included among the top collaborators of Pedro Torres‐González based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pedro Torres‐González. Pedro Torres‐González is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Genotypic Characterization of Human Respiratory Syncytial Viruses Detected in Mexico Between 2021 and 2024 Viruses Rosa María Wong‐Chew, Pedro Torres‐González et al. 0
2 Deep learning for the identification of Candida spp. directly from blood culture gram stains from candidemia patients Medical Mycology Areli Martínez‐Gamboa, María Fernanda González-Lara et al. 0
3 Mycobacterium tuberculosis lineage 4 associated with cavitations and treatment failure BMC Infectious Diseases Pedro Torres‐González, Leticia Ferreyra-Reyes et al. 2
4 Mycobacterial Growth Inhibition Assay (MGIA) as a Host Directed Diagnostic Tool for the Evaluation of the Immune Response in Subjects Living With Type 2 Diabetes Mellitus Frontiers in Cellular and Infection Microbiology Miriam Bobadilla-del-Valle, Pedro Torres‐González et al. 3
5 Simvastatin Enhances the Immune Response Against Mycobacterium tuberculosis Frontiers in Microbiology Miriam Bobadilla-del-Valle, Isabel Sada‐Ovalle et al. 35
6 Potential Effect of Statins onMycobacterium tuberculosisInfection Journal of Immunology Research Pedro Torres‐González, Miriam Bobadilla-del-Valle et al. 18
7 Factors associated with an outbreak of hospital-onset, healthcare facility-associated Clostridium difficile infection (HO-HCFA CDI) in a Mexican tertiary care hospital: A case-control study PLoS ONE Eric Ochoa‐Hein, José Sifuentes‐Osornio et al. 8
8 Mycobacterium tuberculosis complex bacteremia among HIV and non-HIV patients in a Mexican tertiary care center The Brazilian Journal of Infectious Diseases Karla M. Tamez‐Torres, Pedro Torres‐González et al. 4
9 Genotyping and spatial analysis of pulmonary tuberculosis and diabetes cases in the state of Veracruz, Mexico PLoS ONE Luis Pablo Cruz‐Hervert, Leticia Ferreyra-Reyes et al. 10
10 Tuberculosis and systemic lupus erythematosus: a case-control study in Mexico City Clinical Rheumatology Pedro Torres‐González, Juanita Romero‐Díaz et al. 16
11 Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis BMC Infectious Diseases María Fernanda González-Lara, Pedro Torres‐González et al. 17
12 Impact of Clostridium difficile infection caused by the NAP1/RT027 strain on severity and recurrence during an outbreak and transition to endemicity in a Mexican tertiary care center International Journal of Infectious Diseases Karla M. Tamez‐Torres, Pedro Torres‐González et al. 17
13 Molecular clustering of patients with diabetes and pulmonary tuberculosis: A systematic review and meta-analysis PLoS ONE Guadalupe Delgado-Sánchez, Norma Mongua-Rodríguez et al. 16
14 Identification and susceptibility testing of Candida spp . directly from yeast-positive blood cultures with Vitek 2 Diagnostic Microbiology and Infectious Disease María Fernanda González-Lara, Pedro Torres‐González et al. 0
15 Associated factors and outcomes for OXA-232 Carbapenem-resistant Enterobacteriaceae infections in a tertiary care centre in Mexico City: A case–control-control study Diagnostic Microbiology and Infectious Disease Pedro Torres‐González, Edgar Ortíz‐Brizuela et al. 7
16 Human tuberculosis caused by Mycobacterium bovis: a retrospective comparison with Mycobacterium tuberculosis in a Mexican tertiary care centre, 2000–2015 BMC Infectious Diseases Pedro Torres‐González, Miguel E. Cervera-Hernandez et al. 54
17 Factors Associated to Prevalence and Incidence of Carbapenem-Resistant Enterobacteriaceae Fecal Carriage: A Cohort Study in a Mexican Tertiary Care Hospital PLoS ONE Pedro Torres‐González, Miguel E. Cervera-Hernandez et al. 66
18 Trends of Mycobacterium bovis Isolation and First-Line Anti-tuberculosis Drug Susceptibility Profile: A Fifteen-Year Laboratory-Based Surveillance PLoS neglected tropical diseases Miriam Bobadilla-del-Valle, Pedro Torres‐González et al. 35
19 Outbreak Caused by Enterobacteriaceae Harboring NDM-1 Metallo-β-Lactamase Carried in an IncFII Plasmid in a Tertiary Care Hospital in Mexico City Antimicrobial Agents and Chemotherapy Pedro Torres‐González, Miriam Bobadilla-del-Valle et al. 50
20 Prevalence of Latent and Active Tuberculosis among Dairy Farm Workers Exposed to Cattle Infected by Mycobacterium bovis PLoS neglected tropical diseases Pedro Torres‐González, Areli Martínez‐Gamboa et al. 55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026